Heidelberg university hospital in germany invests in fourth accuray radiotherapy device, the radixact® system, to improve cancer patient care

The radixact system will be supplied with clearrt®, synchrony®, and the volo™ ultra optimizer to enhance radiation treatment delivery precision and speed heidelberg university hospital is recognized worldwide for excellence in patient care and practice changing research madison, wis. , june 27, 2024 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today that long-term customer heidelberg university hospital in heidelberg, germany, has selected the company's radixact ® system, equipped with its proprietary clearrt ®, synchrony ® and volo™ ultra optimizer solutions, to help transform their approach to cancer care.
ARAY Ratings Summary
ARAY Quant Ranking